Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial

- Parsons, Mark W., Yogendrakumar, Vignan, Ng, Felix C., Deepak, Akshay, Choi, Philip M. C., Kleinig, Timothy J., Cordato, Dennis J., Wu, Teddy Y., Fink, John N., Ma, Henry, Phan, Thanh G., Markus, Hugh S., Churilov, Leonid, Molina, Carlos A., Tsai, C-H, Lee, J-T, Jeng, J-S, Strbian, D, Meretoja, A, Arenillas, JF, Buck, BH, Devlin, MJ, Brown, H, Garcia-Esperon, Carlos, Butcher, KS, O'Brien, B, Sabet, A, Wijeratne, T, Bivard, A, Grimley, RS, Agarwal, S, Munshi, SK, Donnan, GA, Davis, SM, Campbell, Bruce C. V., Miteff, Ferdinand, Spratt, Neil J., Levi, Christopher R., TASTE investigators,, Russell, Michelle L., Sharma, Gagan, Chen, Chushuang, Lin, Longting, Chew, Beng Lim

Improving access to acute stroke therapies: a controlled trial of organised pre-hospital and emergency care

- Quain, Debbie A., Parsons, Mark W., Attia, John, McElduff, Patrick, Levi, Christopher R., Loudfoot, Allan R., Spratt, Neil, Evans, Malcolm K., Russell, Michelle L., Royan, Angela T., Moore, Andrea G., Miteff, Ferdinand, Hullick, Carolyn J.